Using a high-throughput screening process, scientists have for the first time identified molecules with the potential to block the accumulation of a toxic eye protein. This protein called myocilin can lead to early onset of glaucoma. Researchers have implicated a mutant form of a protein a possible root cause of this increased eye pressure. This cascade of events can lead to early onset-glaucoma, which affects several million people from childhood to age 35. The study was published on Nov. 26, 2013, in the journal ACS Chemical Biology.
First potential drug targets for glaucoma
Comments are closed.